Clinical Trials

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
(New page: Clinical Trials involve the following Phases Testing in Humans Number of Patients Length Purpose Per...)
Line 6: Line 6:
                 Number of Patients                  Length                  Purpose                Percent of Drugs Successfully Tested
                 Number of Patients                  Length                  Purpose                Percent of Drugs Successfully Tested
-
  Phase I     20 - 100                    Several months            Mainly safety                        70 percent
+
  [[Phase I]]     20 - 100                    Several months            Mainly safety                        70 percent
-
  Phase II Upto several hundred      Several months to 2 years  Some short-term safety,                  33 percent
+
  [[Phase II]] Upto several hundred      Several months to 2 years  Some short-term safety,                  33 percent
                                                                       but mainly effectiveness
                                                                       but mainly effectiveness
-
  Phase III      Several hundred to            1 - 4 years            Safety, effectiveness, dosage            25 - 30 percent
+
  [[Phase III]]       Several hundred to            1 - 4 years            Safety, effectiveness, dosage            25 - 30 percent
                 several thousand
                 several thousand
-
  Phase IV Click here for revelant details
+
  [[Phase IV]]

Revision as of 04:58, 31 July 2008

Clinical Trials involve the following Phases

Testing in Humans


               Number of Patients                  Length                   Purpose                Percent of Drugs Successfully Tested
Phase I 	    20 - 100                    Several months             Mainly safety                         70 percent
Phase II 	Upto several hundred       Several months to 2 years   Some short-term safety,                   33 percent
                                                                      but mainly effectiveness
Phase III       Several hundred to             1 - 4 years             Safety, effectiveness, dosage             25 - 30 percent
                several thousand
Phase IV